TwinBeech Capital’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,729
Closed -$210K 775
2024
Q3
$210K Sell
7,729
-6,610
-46% -$200K ﹤0.01% 638
2024
Q2
$412K Buy
+14,339
New +$440K 0.01% 465
2024
Q1
Sell
-10,413
Closed -$339K 723
2023
Q4
$339K Sell
10,413
-2,872
-22% -$83.3K 0.01% 570
2023
Q3
$425K Buy
+13,285
New +$512K 0.01% 552
2022
Q4
Sell
-11,679
Closed -$539K 815
2022
Q3
$539K Buy
+11,679
New +$573K 0.01% 517
2022
Q2
Sell
-6,294
Closed -$340K 613
2022
Q1
$340K Buy
+6,294
New +$322K 0.02% 418
2021
Q1
Sell
-9,036
Closed -$373K 563
2020
Q4
$373K Buy
+9,036
New +$414K 0.06% 333

Other funds holding KIDS

TwinBeech Capital's KIDS Position: Q4 2024 in Review

TwinBeech Capital sold out of OrthoPediatrics (KIDS) in Q4 2024, closing a stake of 7,729 shares — an estimated $210K sold.

TwinBeech Capital first reported a position in KIDS in Q4 2020 and held it in 7 quarters. The position peaked at $539K in Q3 2022. 108 funds tracked by Wall St. Rank hold KIDS as of Q4 2024.

  • TwinBeech Capital reported no remaining OrthoPediatrics position as of Q4 2024 after selling out during the quarter.
  • TwinBeech Capital sold 7,729 OrthoPediatrics shares in Q4 2024, an estimated $210K.
  • TwinBeech Capital first reported a position in OrthoPediatrics in Q4 2020 and held it in 7 quarters.
  • TwinBeech Capital's OrthoPediatrics position peaked at $539K in Q3 2022.
  • 108 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2024.

Based on TwinBeech Capital's 13F filing for Q4 2024, filed 14 Feb 2025.